RxTeach
  • Home
  • Clinical Pharmacy
  • Journal Clubs
  • Pharmacy Industry
  • Health & Wellness
  • Students
  • Donations
  • About
  • Day in the Life
  • Science
  • Connect with us!
Sign in Subscribe
Clinical Pharmacy

Let's Talk Vancomycin: Part 2

Today, we’ll continue our deep dive with vanc and learn more about how we might approach dosing and calculations!

  • Justin Shiau, PharmD

Justin Shiau, PharmD

20 Feb 2025 • 16 min read
Let's Talk Vancomycin: Part 2
Photo by insung yoon / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

OASIS-4 Journal Club
Members only

OASIS-4 Journal Club

Journal club review of the OASIS-4 trial evaluating oral semaglutide 25 mg for weight loss, including efficacy, safety outcomes, and clinical impact.
04 Feb 2026 4 min read
The Importance of a Value Proposition

The Importance of a Value Proposition

Why great drugs fail without a story: how pharma value propositions turn clinical data into stakeholder-specific impact and market access.
29 Jan 2026 5 min read
Hypervolemic Hyponatremia

Hypervolemic Hyponatremia

Hyponatremia in hypervolemic patients explained: risks in older adults, safe sodium correction, and treatment options including loop diuretics and vaptans.
28 Jan 2026 7 min read
RxTeach © 2026
Powered by Ghost